经膀胱单孔多通道腹腔镜治疗前列腺增生的有效性及安全性评价  

Efficacy and safety of laparoendoscopic single-site surgery in benign prostatic hyperplasia

作　　者：黄锐[1] 陈景宇[1] 

机构地区：[1]惠州市第一人民医院泌尿外科,广东惠州516000

出　　处：《国际泌尿系统杂志》2016年第3期343-346,共4页International Journal of Urology and Nephrology

基　　金：广东省惠州市科技计划项目（2013Y054）

摘　　要：目的 评价分析经膀胱单孔多通道腹腔镜治疗前列腺增生的有效性及安全性.方法 按照随机数字表法将本研究收治的60例前列腺增生患者分为对照组和观察组（分别为30例）,对照组实施常规开放手术治疗;观察组实施经膀胱单孔多通道腹腔镜下前列腺剜除术;并观察两组患者术中出血量、平均手术时间、术后IPSS评分、最大尿流率、住院时间和并发症发生率.结果 观察组患者手术时间、术中出血量以及住院时间明显少于对照组（P＜0.05）;而观察组患者术后IPSS评分和最大尿流率与对照组相比差异没有统计学意义（P＞0.05）;观察组并发症发生率为3.33％,对照组并发症发生率为16.67％,两组比较差异有统计学意义（P＜0.05）.结论 经膀胱单孔多通道腹腔镜腺癌前列腺剜除术在前列腺增生患者治疗中应用,创伤小、术中输血量、手术时间以及并发症和住院时间少,效果显著,可行性高,值得临床推广使用.Objectives To evaluate the efficacy and safety of laparoendoscopic single-site （LESS） surgery in treatment of benign prostatic hyperplasia.Methods A total of 60 benign prostatic hyperplasia（BPH） cases were equally assigned to 2 groups according to the random number table：control group （Open operation group） and observation group （LESS group）.The clinical parameters include blood loss,operation time,international prostate symptoms score （IPSS）,maximum urine flow rate（Q max）,hospital stays and postoperative complication rate.Results In blood loss and operation time,LESS group was significantly less than control group（P 〈0.05）.In postoperative complication rate,LESS group（3.33%） was lower than control group（16.67%,P 〈0.05）.There was no significant difference between two groups in IPSS and Q max（P 〉 0.05）.Conclusions Compare with traditional open operation,Laparoendoscopic single-site surgery of BPH has advantages in minimally invasive,less blood loss,less operation time and hospital stays,lower postoperative complication rate.It＆#39; s worthy for clinical use.

关 键 词：前列腺增生 膀胱 腹腔镜 前列腺增生 膀胱 腹腔镜 

分 类 号：R699.8[医药卫生—泌尿科学]